Drug reference

Digoxin-specific antibody

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 1462

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

Treatment of known or strongly suspected life- threatening digoxin toxicity associated with ventricular arrhythmias or bradyarrhythmias unresponsive to atropine and when measures beyond the withdrawal of digoxin and correction of any electrolyte abnormalities are considered necessary ▶BY INTRAVENOUS INFUSION Emergency treatment of poisoning ▶Child: Serious cases of digoxin toxicity should be discussed with the National Poisons Information Service (consult product literature) ▶Adult: Serious cases of digoxin toxicity should be discussed with the National Poisons Information Service (consult product literature)

PDF page 1462

Dose and formulations

Directions For Administration

▶In adults For intravenous infusion (DigiFab ®), given intermittently in Sodium chloride 0.9%. Reconstitute with water for injections (4 mL/vial), then dilute with infusion ﬂuid and give over 30 minutes.

PDF page 1462

Medicinal Forms

There can be variation in the licensing of different medicines containing the same drug. Powder for solution for infusion ▶DigiFab (BTG International Ltd) Digoxin-specific antibody fragments 40 mg DigiFab 40mg powder for solution for infusion vials | 1 vial P £750.00 (Hospital only) 3.3 Heparin toxicity ANTIDOTES AND CHELATORS

PDF page 1462

Dose text by age group

Child

Serious cases of digoxin toxicity should be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1462

Adult

Serious cases of digoxin toxicity should be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1462

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

Digoxin-specific antibody

BNF 80 (2020–2021)

Source: BNF 80 (2020–2021)
PDF pages: 1462

Review source pages for extracted sections and age labels. BNF dose snippets show only their first line.

Overview

Indications And Dose

PDF page 1462

Dose and formulations

Directions For Administration

PDF page 1462

Medicinal Forms

PDF page 1462

Dose text by age group

Child

Serious cases of digoxin toxicity should be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1462

Adult

Serious cases of digoxin toxicity should be

First-line fragment. Read the complete Indications and Dose section above.

PDF page 1462

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.